Brad is the VP of Business Development at INCOG BioPharma and brings 20+ years of extensive and diverse life sciences industry experience to their leadership team. Prior to joining, Brad served as the Chief Financial Officer at Exelead, where he led the finance, business development, supply chain, project management, and IT organizations. Brad directed the acquisition of Exelead by Merk KGaA and its U.S. subsidiary MiliporeSigma in 2022. Prior to that, he held senior leadership roles in finance at Catalent and Covance/LabCorp.